Literature DB >> 20532607

Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis.

Katherine Tassiopoulos1, Jennifer S Read, Susan Brogly, Kenneth Rich, Barry Lester, Stephen A Spector, Ram Yogev, George R Seage.   

Abstract

We evaluated prenatal substance use in a cohort of 480 HIV-infected women and their uninfected children. Substance use was reported by 29%; the most common substances reported were tobacco (18%), alcohol (10%), and marijuana (7.2%). Fewer than 4% of women reported cocaine or opiate use. Substance use was more common in the first trimester (25%) than the second (17%) and third (15%) (trend p-value <0.01), and was associated with race/ethnicity, education, birthplace, age and marital status. For 264 mother/infant pairs with meconium results, sensitivity of self-report was 86% for tobacco, 80% for marijuana and 67% for cocaine. Higher discordance between self-report and urine/blood toxicology was observed for cocaine, marijuana and opiates in a non-random subset of mothers/infants with these tests. Findings suggest reasonably complete self-reporting of substance use as confirmed by meconium analysis. Illicit substance use was low and substantially less than that reported in earlier studies of HIV-infected women, but alcohol and tobacco exposure was prevalent.

Entities:  

Mesh:

Year:  2010        PMID: 20532607      PMCID: PMC3098043          DOI: 10.1007/s10461-010-9705-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  54 in total

1.  Substance use and prenatal care during pregnancy among young women.

Authors:  J C Abma; F L Mott
Journal:  Fam Plann Perspect       Date:  1991 May-Jun

2.  Quinolones and false-positive urine screening for opiates by immunoassay technology.

Authors:  L R Baden; G Horowitz; H Jacoby; G M Eliopoulos
Journal:  JAMA       Date:  2001-12-26       Impact factor: 56.272

3.  Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study.

Authors:  E M Ostrea; M Brady; S Gause; A L Raymundo; M Stevens
Journal:  Pediatrics       Date:  1992-01       Impact factor: 7.124

4.  Acute neonatal effects of cocaine exposure during pregnancy.

Authors:  Charles R Bauer; John C Langer; Seetha Shankaran; Henrietta S Bada; Barry Lester; Linda L Wright; Heidi Krause-Steinrauf; Vincent L Smeriglio; Loretta P Finnegan; Penelope L Maza; Joel Verter
Journal:  Arch Pediatr Adolesc Med       Date:  2005-09

5.  Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds.

Authors:  S L Leech; G A Richardson; L Goldschmidt; N L Day
Journal:  Neurotoxicol Teratol       Date:  1999 Mar-Apr       Impact factor: 3.763

Review 6.  Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review.

Authors:  D A Frank; M Augustyn; W G Knight; T Pell; B Zuckerman
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

7.  Prenatal exposure to tobacco: II. Effects on cognitive functioning at age three.

Authors:  M Sexton; N L Fox; J R Hebel
Journal:  Int J Epidemiol       Date:  1990-03       Impact factor: 7.196

8.  Mitochondrial dysfunction: patient monitoring and toxicity management.

Authors:  Grace McComsey; J Tyler Lonergan
Journal:  J Acquir Immune Defic Syndr       Date:  2004-09-01       Impact factor: 3.731

9.  HIV women's health: a study of gynecological healthcare service utilization in a U.S. urban clinic population.

Authors:  Monique A Tello; Hsin-Chieh Yeh; Jean M Keller; Mary C Beach; Jean R Anderson; Richard D Moore
Journal:  J Womens Health (Larchmt)       Date:  2008-12       Impact factor: 2.681

10.  The utility of drug testing in epidemiological research: results from a general population survey.

Authors:  Michael Fendrich; Timothy P Johnson; Joseph S Wislar; Amy Hubbell; Vina Spiehler
Journal:  Addiction       Date:  2004-02       Impact factor: 6.526

View more
  25 in total

1.  In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.

Authors:  Raymond Griner; Paige L Williams; Jennifer S Read; George R Seage; Marilyn Crain; Ram Yogev; Rohan Hazra; Kenneth Rich
Journal:  AIDS Patient Care STDS       Date:  2011-06-10       Impact factor: 5.078

2.  Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure.

Authors:  Sarah K Himes; Yanling Huo; George K Siberry; Paige L Williams; Mabel L Rice; Patricia A Sirois; Toni Frederick; Rohan Hazra; Marilyn A Huestis
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

3.  Prevalence, incidence, and persistence of psychiatric and substance use disorders among mothers living with HIV.

Authors:  Kathleen M Malee; Claude A Mellins; Yanling Huo; Katherine Tassiopoulos; Renee Smith; Patricia A Sirois; Susannah M Allison; Deborah Kacanek; Suad Kapetanovic; Paige L Williams; Mitzie L Grant; Daniel Marullo; Angela A Aidala
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

4.  Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012.

Authors:  Kathryn Rough; Katherine Tassiopoulos; Deborah Kacanek; Raymond Griner; Ram Yogev; Kenneth C Rich; George R Seage
Journal:  AIDS       Date:  2015-01-02       Impact factor: 4.177

5.  Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.

Authors:  George K Siberry; Paige L Williams; Hermann Mendez; George R Seage; Denise L Jacobson; Rohan Hazra; Kenneth C Rich; Raymond Griner; Katherine Tassiopoulos; Deborah Kacanek; Lynne M Mofenson; Tracie Miller; Linda A DiMeglio; D Heather Watts
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

Review 6.  Mental health of HIV-seropositive women during pregnancy and postpartum period: a comprehensive literature review.

Authors:  Suad Kapetanovic; Priscilla Dass-Brailsford; Diana Nora; Nicholas Talisman
Journal:  AIDS Behav       Date:  2014-06

7.  Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium.

Authors:  Sarah K Himes; Karl B Scheidweiler; Katherine Tassiopoulos; Deborah Kacanek; Rohan Hazra; Kenneth Rich; Marilyn A Huestis
Journal:  Anal Chem       Date:  2013-01-14       Impact factor: 6.986

8.  Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.

Authors:  Paige L Williams; Rohan Hazra; Russell B Van Dyke; Cenk Yildirim; Marilyn J Crain; George R Seage; Lucy Civitello; Angela Ellis; Laurie Butler; Kenneth Rich
Journal:  AIDS       Date:  2016-01-02       Impact factor: 4.177

9.  Combination antiretroviral use and preterm birth.

Authors:  D Heather Watts; Paige L Williams; Deborah Kacanek; Raymond Griner; Kenneth Rich; Rohan Hazra; Lynne M Mofenson; Hermann A Mendez
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

10.  Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.

Authors:  Patricia A Sirois; Yanling Huo; Paige L Williams; Kathleen Malee; Patricia A Garvie; Betsy Kammerer; Kenneth Rich; Russell B Van Dyke; Molly L Nozyce
Journal:  Pediatr Infect Dis J       Date:  2013-06       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.